Tailored glycoprotein platform for improved micronutrient delivery
This innovative platform utilizes modified glycoproteins to enhance the delivery of essential micronutrients like iron, calcium, and zinc. It offers a scalable, sustainable solution by enhancing mineral chelation and antioxidant activity, improving bioavailability and stability.
Overview
The tailored glycoprotein platform is designed to revolutionize the delivery of essential micronutrients such as iron, calcium, and zinc. By using structurally modified glycoproteins derived from renewable sources, this solution addresses common challenges like low mineral solubility, oxidative instability, and limited bioavailability. The platform produces two bioactive powders that enhance metal-chelating properties and antioxidant activity, which can be blended to meet specific formulation needs. This dual-powder system offers a clean-label, sustainable approach to micronutrient delivery, combining antioxidant protection with mineral stabilization.
Technical specifications
- Bioactive powders: Two distinct powders with enhanced chelation and antioxidant capacities.
- Glycoprotein-based: Utilizes a single renewable material to replace synthetic additives.
- Compatibility: Naturally soluble and compatible with existing industrial processes.
- Encapsulation techniques: Future exploration includes methods like complex coacervation and spray drying to optimize encapsulation efficiency.
- Modular blending: Allows for precise tailoring of functional properties to specific needs.
- In vitro testing: Simulated gastrointestinal studies will evaluate micronutrient stability and release behavior.
Technology readiness level
The glycoprotein platform is at Technology Readiness Level 3. Current efforts focus on optimizing encapsulation techniques and validating micronutrient delivery efficiency through in vitro testing under simulated conditions.
About Tel Aviv University
Tel Aviv University is one of Israel’s largest comprehensive public research universities with a broad academic portfolio and strong research culture. Located in Tel Aviv’s dense startup and multinational R&D corridor, it engages industry through sponsored research, shared-use facilities, executive education, and access to top talent. A dedicated technology transfer company manages IP, licensing, and venture creation, complemented by entrepreneurship programs and proof‑of‑concept support; clinical collaborations across the city’s healthcare ecosystem enable translation. Research is supported by competitive national agencies and international programs, including the Israel Innovation Authority and European research frameworks. Corporate engagement offices streamline scoping and agreements, giving partners clear entry points.
delivered to your inbox.